PRT1419
PRT1419-01
Phase 1 small_molecule completed
Quick answer
PRT1419 for Multiple Myeloma is a Phase 1 program (small_molecule) at Prelude Therapeutics Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prelude Therapeutics Inc
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed